NO179005C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,2,4-benzotriazinoksider - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,2,4-benzotriazinoksider

Info

Publication number
NO179005C
NO179005C NO904003A NO904003A NO179005C NO 179005 C NO179005 C NO 179005C NO 904003 A NO904003 A NO 904003A NO 904003 A NO904003 A NO 904003A NO 179005 C NO179005 C NO 179005C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogous process
benzotriazine oxides
disclosed
Prior art date
Application number
NO904003A
Other languages
English (en)
Other versions
NO904003D0 (no
NO179005B (no
NO904003L (no
Inventor
William W Lee
J Martin Brown
Edward W Grange
Abelardo P Martinez
Michael Tracy
Original Assignee
Stanford Res Inst Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Res Inst Int filed Critical Stanford Res Inst Int
Publication of NO904003D0 publication Critical patent/NO904003D0/no
Publication of NO904003L publication Critical patent/NO904003L/no
Publication of NO179005B publication Critical patent/NO179005B/no
Publication of NO179005C publication Critical patent/NO179005C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C07D253/10—Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO904003A 1988-03-18 1990-09-13 Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,2,4-benzotriazinoksider NO179005C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16987388A 1988-03-18 1988-03-18
PCT/US1989/001037 WO1989008647A1 (en) 1988-03-18 1989-03-15 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents

Publications (4)

Publication Number Publication Date
NO904003D0 NO904003D0 (no) 1990-09-13
NO904003L NO904003L (no) 1990-09-13
NO179005B NO179005B (no) 1996-04-09
NO179005C true NO179005C (no) 1996-07-17

Family

ID=22617563

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904003A NO179005C (no) 1988-03-18 1990-09-13 Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,2,4-benzotriazinoksider

Country Status (14)

Country Link
EP (1) EP0413706B1 (no)
JP (1) JP2793312B2 (no)
KR (1) KR0140894B1 (no)
AT (1) ATE170515T1 (no)
AU (1) AU637572B2 (no)
CA (1) CA1339217C (no)
DE (1) DE68928802T2 (no)
DK (1) DK175885B1 (no)
ES (1) ES2013123A6 (no)
IE (1) IE62911B1 (no)
NO (1) NO179005C (no)
NZ (1) NZ228323A (no)
PT (1) PT90039B (no)
WO (1) WO1989008647A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU646794B2 (en) * 1989-09-18 1994-03-10 Sri International 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
US5110347A (en) * 1990-11-26 1992-05-05 E. I Du Pont De Nemours And Company Substituted fused heterocyclic herbicides
WO2005082867A1 (en) * 2004-03-01 2005-09-09 Auckland Uniservices Limited Novel 1,2,4-benzotriazine-1,4-dioxides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2489352A (en) * 1946-04-10 1949-11-29 Merck & Co Inc Halogen compounds of 3 aminobenzotriazine 1, 2, 4 oxide-1
US2489359A (en) * 1947-01-10 1949-11-29 Merck & Co Inc Benzotriazines
CH487171A (de) * 1963-10-22 1970-03-15 Siegfried Ag Verfahren zur Herstellung therapeutisch wirksamer 1,2-Dihydro-1,2,4-benztriazine
DE1809390A1 (de) * 1968-11-16 1970-06-11 Bayer Ag Phosphor-,Phosphon- bzw.Thionophosphor-(-phosphon)-saeureester und Verfahren zu ihrer Herstellung
DE2255825C3 (de) * 1972-11-15 1978-03-30 Bayer Ag, 5090 Leverkusen Mikrobizide Mittel auf der Basis von S-N-Aminobenzo-l^-Triazin-di-N-oxiden (1,4)
IE38778B1 (en) * 1973-02-02 1978-05-24 Ciba Geigy New 1,2,4-benzotriazine derivatives
SE7501624L (no) * 1974-03-15 1975-09-16 Ciba Geigy Ag
DE2538179C2 (de) * 1975-08-27 1986-05-28 Bayer Ag, 5090 Leverkusen 3-Alkoxy-benzo-1,2,4-triazine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Fungizide
US4091098A (en) * 1977-04-25 1978-05-23 Merck & Co., Inc. 3-(1-PIPERAZINYL)-1,2,4-BENZOTRIAZINES AND N-oxides
DE2740887A1 (de) * 1977-09-10 1979-03-22 Bayer Ag Mittel zur bekaempfung von pflanzenbakteriosen
WO1988002366A1 (en) * 1986-09-25 1988-04-07 Sri International 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents

Also Published As

Publication number Publication date
DK223090D0 (da) 1990-09-17
DE68928802D1 (de) 1998-10-08
KR900700466A (ko) 1990-08-13
AU637572B2 (en) 1993-06-03
AU3433789A (en) 1989-10-05
JPH03505867A (ja) 1991-12-19
NO904003D0 (no) 1990-09-13
DE68928802T2 (de) 1999-04-01
EP0413706A1 (en) 1991-02-27
EP0413706B1 (en) 1998-09-02
NO179005B (no) 1996-04-09
ES2013123A6 (es) 1990-04-16
KR0140894B1 (ko) 1998-06-01
CA1339217C (en) 1997-08-05
NZ228323A (en) 1992-09-25
DK223090A (da) 1990-11-15
ATE170515T1 (de) 1998-09-15
DK175885B1 (da) 2005-05-23
PT90039B (pt) 1994-05-31
JP2793312B2 (ja) 1998-09-03
IE62911B1 (en) 1995-03-08
NO904003L (no) 1990-09-13
PT90039A (pt) 1989-11-10
IE890721L (en) 1989-09-18
WO1989008647A1 (en) 1989-09-21

Similar Documents

Publication Publication Date Title
FI91152B (fi) Menetelmä terapeuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
FI891492A0 (fi) Menetelmä terapeuttisesti aktiivisten bis-(hydroksimetyyli)syklobutyylipuriinien ja -pyrimidiinien valmistamiseksi
NO162965C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydrotieno-(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater.
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
GB8824869D0 (en) Synthetic antibody
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
FI96601C (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
FI871087A0 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
FI884471A (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI890257A (fi) Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
FI892684A (fi) Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
NO179005C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,2,4-benzotriazinoksider
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
FI894520A (fi) Menetelmä terapeuttisesti aktiivisten 8-aminosubstituoitu-7,8-dihydro-6,6-dimetyyli-6H-pyrano/2,3-f/bentso-2,1,3-oksadiatsolien valmistamiseksi
IT1039756B (it) Procedimento per migliopare l at tivita di enzimi ossidoriduttasici inglobati in strutture filamentose
JPS5297926A (en) Process for preparing pharmaceutically active compound* its composition and therapeutical method by utilization thereof
HUT42102A (en) Process for preparing peptides with pharmaceutical activity
JPS54138530A (en) Dilignol and dilignol analogur compound as hepatitis therapeutically active substance
IL82937A0 (en) Pyrrolinylacetamide,processes for the preparation thereof and the use thereof
NO854277L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 6-fenetylaminoalkyl-7-hydroksy-furo-(3,4-c)-pyridin-derivater.
GR1000941B (el) Μεθοδος παρασκευης οξειδιων 1,2,4,βενζοτριαζινης.
FI893121A0 (fi) Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi
NO943458D0 (no) Fremgangsmåte for fremstilling av terapeutisk aktivt amphiregulin
DE3563416D1 (en) Hexetidin-containing therapeutically active agent, method for its preparation and its use as a vaginal disinfectant
NO175099C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3,5-tritianderivater

Legal Events

Date Code Title Description
MK1K Patent expired